Senior insider sale
RVL PHARMACEUTICALS PLC — senior position signals high conviction
$248.1K
1.84M shares
What this filing means
VENKATARAMAN SRIRAM plans to sell 1.84M shares of RVL PHARMACEUTICALS PLC valued at approximately $248.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/30/2023ACC: 0001961863-23-000101
Director10% Owner
Since Oct 2018
1.84M
Shares to sell
$248.1K
Approx. market value
300.85K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Private Placement
Private placement
8/8/2022
300.85KTotal acquired300.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/8/2022 | Private Placement Private placement | 300.85K | — |
| Total | 300.85K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
767.51K
Market value
$107.5K
8/24/2023
—Completed
Units to sell
767.51K
Market value
$107.5K
8/24/2023
—Completed
Units to sell
140.77K
Market value
$17.2K
8/24/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
160.08K
Market value
$16.0K
8/30/2023
Total
Units
1.84M
Value
$248.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/24/2023 | 767.51K | $107.5K | — | Completed |
8/24/2023 | 767.51K | $107.5K | — | Completed |
8/24/2023 | 140.77K | $17.2K | — | Completed |
| Planned — Approximate Date | ||||
8/30/2023 | 160.08K | $16.0K | NASDAQ | Planned |
| Total | 1.84M | $248.1K | ||